Mutia, Fernanda .

HRN: 20-20-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/18/2026
03/18/2026
IV
4.5G
LD
CAP-MR
Remove - Pending Acceptance
03/18/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/18/2026
03/25/2026
IV
2.25G
Q8H
Pneumonia
Remove - Pending Acceptance
03/18/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/18/2026
03/25/2026
IV
600MG
Q6H
SACRAL ULCER
Remove - Pending Acceptance
03/18/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
03/18/2026
03/25/2026
TOPICAL
1%
BID
SACRA
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: